Cite
HARVARD Citation
Peyrin-Biroulet, L. et al. (n.d.). OP16 Endoscopic and clinical outcomes of upadacitinib in patients with moderately to severely active Crohn's disease by number and type of prior biologics. Journal of Crohn's and colitis. pp. i20-i22. [Online].